Загрузка...
Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS
OBJECTIVE: To better understand ozanimod's mechanism of action (MOA), we conducted exploratory analyses from a phase 1 study to characterize ozanimod's effect on circulating leukocyte subsets in patients with relapsing multiple sclerosis. METHODS: An open-label pharmacodynamic study random...
Сохранить в:
| Опубликовано в: : | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott Williams & Wilkins
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7413711/ https://ncbi.nlm.nih.gov/pubmed/32737072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000839 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|